Post Transcription Flashcards
1
Q
mRNA structure in eukaryotes
A
- Eukaryote mRNA contains a 7-methyl guanine cap on the 5 end and polyadenylation tail at the 3 end
2
Q
mRNA structure in prokes
A
- The 5 and 3 ends of bacterial mRNA are unmodified
- mRNA polycistronic
- encode for multiple proteins on the same mRNA
3
Q
what does RNA pol II carry?
A
- Carries a set of pre-mRNA processing proteins on its tail
- Shortly following the initiation of transcription these proteins are transferred to the nascent RNA
- This transfer of RNA processing proteins typically occurs after ~25 nucleotides are produced
4
Q
describe the capping process of mRNA (4 enzymes)
A
- Phosphatase: removes 1 phosphate from the 5 end of the RNA
- Guanylyl transferase: adds a GMP in a reverse linkage (5’ to 5’ instead of 5’ to 3’)
- Guanine-7-methyl transferase: adds a methyl group to the 7 position of the terminal guanine
- 2’O-methyl transferase: adds a methyl group to the 2’-O position to the next to last base on the 5’end
5
Q
what are the 3 functions of 5’ mRNA capping
A
-
Regulates export of mRNA out of the nucleus
- mRNA is exported in complexes that contain a Cap Binding Complex (CBC) at the 5’ end and RNA binding proteins along the rest of sequence
-
Required for the efficient translation of the mRNA into protein
- The CBC is replaced by translation factors which facilitates binding of mRNA to the ribosome
-
Prevents 5’ degradation
- The CBC and elF block the access of de-capping enzymes to the cap. Increase half life of mRNA
6
Q
name the enzymes invovled in the 3’ mRNA polyadenylation in Euks
A
- Cleavage and polyadenylation specificity factor (CPSF) binds to the polyadenylation signal
- Cleavage stimulating factor F (CstF) binds the GU-rich element beyond the cleavage site
- Cleavage factors bind to the CA sequence at the cleavage site
7
Q
describe the polyadenylation sequence
A
- Poly-A-polymerase (PAP) adds 200 A nucleotides to the 3’ end produced by the cleavage
- Poly-A Binding Protieins (PABP) binds to the poly-A tail and assist in directing translation by the ribosome
- The cleaved fragment of the RNA is degraded in the nucleus
8
Q
name the 4 functions of 3’ mRNA polyadenylation
A
- Increases the half life of the mRNA by protecting it from enzymatic degradation in the cytoplasm
- PolyA-binding protein (PABP) binds to tail protecting mRNAs from ribonuclease attack
- PABP interacts with e-IF 4G and this interaction leads to stimulation of translation of euk mRNAs
- Aids in transcription termination
- Aids in export of the mRNA from the nucleus
9
Q
describe the structure of introns
A
- Splice donor site (at the beginning): GU
- Conserved Branch Point Sequence (in the middle): A
- Splice acceptor site (at end): AG
10
Q
steps of intron removal by spliceosome
A
- U1 snRNP binds to the 5’ splice junctions and U2 binds to the branch point
- Interactions with U4/U6 snRNP and U5 snRNP binds U1 and U2 together to form a loop
- U4 dissociates forming the active spliceosome
- The spliceosome complex cleave the intron from exon 1 at the 5’ splice junction. The free end binds to the A in the branch point sequence (forms lariat)
- The intron is excised by cleavage at the 3’ splice junction and exons 1 and 2 are ligated. snRNPs released.
11
Q
what clinical relevance does problems with spliceosome have?
A
- Systemic Lupus Erythematosis
- Autoimmune disease with multiple symptoms such as fatigue, arthritis, fever, skin rashes and kidney problems
- Individuals with this condition possess antibodies that react with the U1 RNA component of the spliceosome and various other nuclear proteins such as histone and topoisomerases
12
Q
how is alternative RNA splicing controlled?
A
- Alternative splicing can occur due to intron sequence ambiguity
- Due to “weak” splice site sequences and therefore splicing choice occurs by chance
- Directed by negative and positive control via proteins that bind to splice sequences and either repress of activate splicing at that site.
13
Q
mutations that destroy or generate new splice sites
A
- B-thalassemia
- Individuals with B-T have mutations in the B-globin gene that generate additional splice site within the mRNA
- As a result, frame shifts or premature stop codons are introduced into the mature mRNA
- mRNA usually longer than normal
- Results in production of an abnormal B-globin protein in hemoglobin
- can cause severe anemia
14
Q
RNA editing example (liver vs. intestine)
A
- In mammals, the apo-B gene encodes 2 alternative forms of the apolipoprotein B
- In the intestine, the apo-B mRNA is edited so that a premature stop codon is produced (CAA –> UAA) leading to the synthesis of the shorter Apo-protein
- The editing is accomplished by a cytidine deaminase enzyme
15
Q
RNA editing example (glutamate receptor)
A
-
Editing of the glutamate receptor involves a single base change from A to I (inosine)
- This editing results in a codon change within the mRNA from glutamine to arginine
- The editing affects an amino acid located in the inner wall of the ion channel and alters Ca2+ permeability. This editing is a requirement for proper brain development.
- Accomplished by the enzyme adenosine deaminase